These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 6958957
21. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Poplack DG, Reaman GH, Wesley R. Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015 [Abstract] [Full Text] [Related]
22. Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia. Reaman GH, Ladisch S, Echelberger C, Poplack DG. Cancer; 1980 Jun 15; 45(12):3090-4. PubMed ID: 6930318 [Abstract] [Full Text] [Related]
23. [Present status of chemotherapy in ALL and CLL]. Ogawa M. Gan To Kagaku Ryoho; 1982 Nov 15; 9(11):1882-7. PubMed ID: 6964032 [Abstract] [Full Text] [Related]
24. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse. Garay G, Milone J, Dibar E, Pavlovsky S, Kvicala R, Sackmann Muriel F, Montres Varela D, Eppinger-Helft M. Cancer Chemother Pharmacol; 1983 Nov 15; 10(3):224-6. PubMed ID: 6345018 [Abstract] [Full Text] [Related]
25. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study. Buchanan GR, Rivera GK, Pollock BH, Boyett JM, Chauvenet AR, Wagner H, Maybee DA, Crist WM, Pinkel D. Cancer; 2000 Mar 01; 88(5):1166-74. PubMed ID: 10699908 [Abstract] [Full Text] [Related]
27. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia. Sackmann Muriel F, Svarch E, Pavlovsky S, Bustelo P, Giuntoli J, Vergara B, Garay G, Eppinger-Helft M, Kvicala R, Dibar E. Cancer Treat Rep; 1984 Apr 01; 68(4):581-6. PubMed ID: 6370428 [Abstract] [Full Text] [Related]
28. Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone. Sallan SE, Camitta BM, Frei E, Furman L, Leavitt P, Bishop Y, Jaffe N. Med Pediatr Oncol; 1977 Apr 01; 3(3):281-7. PubMed ID: 284168 [Abstract] [Full Text] [Related]
29. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group. Bleyer WA, Krivit W, Chard RL, Hammond D. Cancer Treat Rep; 1979 Jun 01; 63(6):977-81. PubMed ID: 380803 [Abstract] [Full Text] [Related]
31. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE. Am J Pediatr Hematol Oncol; 1989 Jun 01; 11(2):125-33. PubMed ID: 2665546 [Abstract] [Full Text] [Related]
32. Results of therapy in adult acute lymphocytic leukemia. Einhorn LH, Meyer S, Bond WH, Rohn RJ. Oncology; 1975 Jun 01; 32(5-6):214-20. PubMed ID: 1064827 [Abstract] [Full Text] [Related]
38. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study. Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti TJ, Crist WM. N Engl J Med; 1986 Jul 31; 315(5):273-8. PubMed ID: 3523250 [Abstract] [Full Text] [Related]
39. Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma. Cancer Treat Rep; 1982 Jan 31; 66(1):49-55. PubMed ID: 7053265 [Abstract] [Full Text] [Related]
40. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure. Aur RJ, Simone JV, Pratt CB. Cancer; 1971 Jun 31; 27(6):1332-6. PubMed ID: 5282619 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]